Creative Medical Technology Holdings Inc Quick Ratio (CELZ) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Creative Medical Technology Holdings Inc   (NASDAQ: CELZ)

Creative Medical Technology Holdings Inc 's Quick Ratio

CELZ's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Creative Medical Technology Holdings Inc 's Cash & cash equivalent grew by % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Creative Medical Technology Holdings Inc 's Quick Ratio to 0.36, Quick Ratio remained below Creative Medical Technology Holdings Inc average.

Within Biotechnology & Pharmaceuticals industry 128 other companies have achieved higher Quick Ratio than Creative Medical Technology Holdings Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 0 to 2769.

Explain Quick Ratio?
How much Cash & cash equivalents CELZ´s has?
What are CELZ´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELZ Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 165.17 % 7.81 % -13.64 % -21.95 % -27.25 %
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ 0.36 - - - -
CELZ's Total Ranking # 2769 # 0 # 0 # 0 # 0
Seq. Current Liabilities Change 138.06 % 8.4 % 9.51 % -6.17 % -3.22 %
Seq. Cash & cash equivalent Change - - - - -



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 129
Healthcare Sector # 762
Overall Market # 2769


Quick Ratio Statistics
High Average Low
58.65 5.14 0
(Jun 30 2022)   (Dec 31 2020)




Financial Statements
Creative Medical Technology Holdings Inc 's Current Liabilities $ 1 Millions Visit CELZ's Balance sheet
Creative Medical Technology Holdings Inc 's Cash & cash equivalent $ 0 Millions Visit CELZ's Balance sheet
Source of CELZ's Sales Visit CELZ's Sales by Geography


Cumulative Creative Medical Technology Holdings Inc 's Quick Ratio

CELZ's Quick Ratio for the trailling 12 Months

CELZ Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 29.52 % -15 % -23.05 % -22.4 % -22.44 %
Y / Y Cash & cash equivalent TTM Growth - - - - -
Quick Ratio TTM 0.17 - - - -
Total Ranking TTM # 4154
Seq. Current Liabilities TTM Growth 40.49 % 2.02 % -3.9 % -5.96 % -7.8 %
Seq. Cash & cash equivalent TTM Growth - - - - -

Quick ratio ranking by company, industry and sector >> Back to CELZ Financial Strength Comparisons >> Go to Compare CELZ Quick Ratio to its Competitors

On the trailing twelve months basis CELZ Cash & cash equivalent remained unchanged by % in Q2 2026 year on year, faster than Current Liabilities, this led to